Status:
COMPLETED
Brazil Xience V Everolimus-Eluting Coronary Stent System "Real-World" Outcomes Registry
Lead Sponsor:
Cardiovascular Research Center, Brazil
Conditions:
Arterial Coronary Disease
Eligibility:
All Genders
18+ years
Brief Summary
To evaluate the performance and long-term clinical outcomes of the Xience V everolimus-eluting coronary stent system (EECSS) in the treatment of minimally selective, high risk patients in the real-wor...
Detailed Description
Prospective, multicenter, non-randomized, post-marketing web-based registry.Patients all comers assigned for percutaneous coronary intervention (PCI) who present with at least one angiographically doc...
Eligibility Criteria
Inclusion
- Patients \>18 years of age; clinical indication for elective or emergency PCI with stent implantation of at least one angiographically documented coronary artery lesion; agreement to undergo ALL study protocol follow-ups
- Diseased coronary vessel(s) with the presence of at least one obstruction \>50% diameter stenosis by visual estimation in a major epicardial vessel or a major branch (≥2.50mm), with anatomy suitable for percutaneous treatment with implantation of the Xience V EECSS
Exclusion
- Known illness with life expectancy \<24 months; impossibility to comply with all protocol follow-ups
- Coronary anatomy unsuitable for percutaneous treatment with implantation of the Xience V EECSS
Key Trial Info
Start Date :
September 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 1 2012
Estimated Enrollment :
535 Patients enrolled
Trial Details
Trial ID
NCT00989066
Start Date
September 1 2008
End Date
November 1 2012
Last Update
November 27 2012
Active Locations (24)
Enter a location and click search to find clinical trials sorted by distance.
1
CIAS Unimed Vitória
Vitória, Espírito Santo, Brazil
2
Encore
Goiânia, Goiás, Brazil
3
Hospital Lifecenter
Belo Horizonte, Minas Gerais, Brazil
4
Hospital Mater Dei
Belo Horizonte, Minas Gerais, Brazil